Skip to main content

S&P 500 —

Nasdaq-100 —

Dow —

Nasdaq · Common stock

Replimune Group (REPL)

$12.47 +$1.01 (+8.81%)

Day’s range
$11.36–$12.57
Volume
2.0M

REPL price history

REPL closed at $12.47 on Oct. 26, 2026. Over the past year, its daily close ranged from $1.70 on April 13, 2026 to $15.98 on Sept. 2, 2026.

Source: third-party providers. Daily closing prices, adjusted for stock splits; dividends not included. The price scale runs from $0 to $20, not from zero.
Data table: REPL daily closes, the past year
REPL daily closing prices, Oct. 27, 2025 to Oct. 26, 2026, newest first
DateClose
Oct. 26, 2026$12.47
Oct. 23, 2026$11.46
Oct. 22, 2026$11.99
Oct. 21, 2026$11.72
Oct. 20, 2026$11.42
Oct. 19, 2026$11.05
Oct. 16, 2026$10.86
Oct. 15, 2026$11.75
Oct. 14, 2026$11.39
Oct. 13, 2026$12.11
Oct. 12, 2026$13.07
Oct. 9, 2026$13.42
Oct. 8, 2026$13.04
Oct. 7, 2026$13.20
Oct. 6, 2026$13.25
Oct. 5, 2026$13.15
Oct. 2, 2026$13.07
Oct. 1, 2026$13.45
Sept. 30, 2026$13.24
Sept. 29, 2026$13.00
Sept. 28, 2026$12.56
Sept. 25, 2026$12.36
Sept. 24, 2026$12.60
Sept. 23, 2026$12.96
Sept. 22, 2026$13.47
Sept. 21, 2026$12.87
Sept. 18, 2026$13.07
Sept. 17, 2026$12.87
Sept. 16, 2026$12.96
Sept. 15, 2026$13.03
Sept. 14, 2026$13.11
Sept. 11, 2026$12.92
Sept. 10, 2026$13.24
Sept. 9, 2026$14.45
Sept. 8, 2026$14.77
Sept. 4, 2026$15.04
Sept. 3, 2026$15.29
Sept. 2, 2026$15.98
Sept. 1, 2026$15.67
Aug. 31, 2026$15.30
Aug. 28, 2026$15.50
Aug. 27, 2026$15.60
Aug. 26, 2026$15.88
Aug. 25, 2026$15.80
Aug. 24, 2026$14.71
Aug. 21, 2026$14.77
Aug. 20, 2026$14.05
Aug. 19, 2026$14.81
Aug. 18, 2026$15.58
Aug. 17, 2026$14.63
Aug. 14, 2026$14.97
Aug. 13, 2026$15.19
Aug. 12, 2026$15.24
Aug. 11, 2026$13.65
Aug. 10, 2026$13.67
Aug. 7, 2026$12.06
Aug. 6, 2026$12.86
Aug. 5, 2026$11.83
Aug. 4, 2026$11.92
Aug. 3, 2026$11.91
July 31, 2026$11.20
July 29, 2026$5.41
July 28, 2026$5.35
July 27, 2026$8.63
July 24, 2026$9.70
July 23, 2026$10.46
July 22, 2026$10.75
July 21, 2026$11.00
July 20, 2026$10.51
July 17, 2026$10.23
July 16, 2026$9.52
July 15, 2026$9.68
July 14, 2026$9.87
July 13, 2026$9.94
July 10, 2026$10.99
July 9, 2026$11.11
July 8, 2026$11.12
July 7, 2026$11.51
July 6, 2026$11.47
July 2, 2026$11.58
July 1, 2026$11.22
June 30, 2026$11.07
June 29, 2026$11.20
June 26, 2026$11.63
June 25, 2026$11.13
June 24, 2026$11.27
June 23, 2026$11.42
June 22, 2026$11.18
June 18, 2026$10.19
June 17, 2026$10.00
June 16, 2026$8.78
June 15, 2026$8.96
June 12, 2026$8.88
June 11, 2026$8.62
June 10, 2026$8.47
June 9, 2026$9.24
June 8, 2026$8.97
June 5, 2026$9.47
June 4, 2026$9.87
June 3, 2026$9.98
June 2, 2026$8.87
June 1, 2026$9.00
May 29, 2026$8.69
May 28, 2026$4.68
May 27, 2026$4.70
May 26, 2026$4.60
May 22, 2026$4.91
May 21, 2026$5.22
May 20, 2026$5.16
May 19, 2026$4.70
May 18, 2026$5.01
May 15, 2026$5.22
May 14, 2026$4.93
May 13, 2026$5.30
May 12, 2026$4.09
May 11, 2026$3.74
May 8, 2026$4.07
May 7, 2026$3.34
May 6, 2026$3.44
May 5, 2026$2.87
May 4, 2026$3.03
May 1, 2026$2.50
April 30, 2026$2.57
April 29, 2026$2.38
April 28, 2026$2.57
April 27, 2026$2.68
April 24, 2026$2.42
April 23, 2026$2.85
April 22, 2026$2.27
April 21, 2026$1.86
April 20, 2026$2.07
April 17, 2026$2.17
April 16, 2026$2.19
April 15, 2026$2.28
April 14, 2026$1.95
April 13, 2026$1.70
April 10, 2026$4.76
April 9, 2026$5.91
April 8, 2026$5.89
April 7, 2026$7.80
April 6, 2026$8.54
April 2, 2026$8.41
April 1, 2026$7.61
March 31, 2026$7.65
March 30, 2026$7.20
March 27, 2026$7.22
March 26, 2026$7.54
March 25, 2026$7.56
March 24, 2026$6.97
March 23, 2026$6.98
March 20, 2026$6.98
March 19, 2026$6.89
March 18, 2026$6.76
March 17, 2026$7.00
March 16, 2026$7.36
March 13, 2026$7.14
March 12, 2026$7.58
March 11, 2026$7.90
March 10, 2026$8.23
March 9, 2026$8.63
March 6, 2026$8.07
March 5, 2026$7.04
March 4, 2026$7.25
March 3, 2026$7.17
March 2, 2026$7.16
Feb. 27, 2026$7.65
Feb. 26, 2026$7.69
Feb. 25, 2026$8.20
Feb. 24, 2026$8.36
Feb. 23, 2026$8.39
Feb. 20, 2026$8.64
Feb. 19, 2026$8.55
Feb. 18, 2026$8.04
Feb. 17, 2026$7.26
Feb. 13, 2026$7.97
Feb. 12, 2026$7.98
Feb. 11, 2026$7.76
Feb. 10, 2026$7.80
Feb. 9, 2026$7.78
Feb. 6, 2026$7.75
Feb. 5, 2026$6.93
Feb. 4, 2026$7.00
Feb. 3, 2026$7.38
Feb. 2, 2026$6.98
Jan. 30, 2026$7.03
Jan. 29, 2026$7.39
Jan. 28, 2026$7.36
Jan. 27, 2026$7.53
Jan. 26, 2026$7.56
Jan. 23, 2026$7.71
Jan. 22, 2026$7.90
Jan. 21, 2026$7.26
Jan. 20, 2026$7.01
Jan. 16, 2026$7.04
Jan. 15, 2026$7.30
Jan. 14, 2026$7.71
Jan. 13, 2026$8.04
Jan. 12, 2026$8.11
Jan. 9, 2026$8.03
Jan. 8, 2026$8.23
Jan. 7, 2026$8.92
Jan. 6, 2026$8.45
Jan. 5, 2026$8.42
Jan. 2, 2026$8.90
Dec. 31, 2025$9.72
Dec. 30, 2025$9.82
Dec. 29, 2025$9.76
Dec. 26, 2025$9.96
Dec. 24, 2025$10.09
Dec. 23, 2025$9.72
Dec. 22, 2025$9.93
Dec. 19, 2025$9.88
Dec. 18, 2025$9.69
Dec. 17, 2025$9.66
Dec. 16, 2025$9.61
Dec. 15, 2025$9.95
Dec. 12, 2025$10.18
Dec. 11, 2025$9.87
Dec. 10, 2025$9.82
Dec. 9, 2025$10.30
Dec. 8, 2025$10.73
Dec. 5, 2025$10.61
Dec. 4, 2025$10.53
Dec. 3, 2025$10.32
Dec. 2, 2025$10.00
Dec. 1, 2025$9.71
Nov. 28, 2025$10.00
Nov. 26, 2025$10.06
Nov. 25, 2025$9.53
Nov. 24, 2025$9.39
Nov. 21, 2025$9.20
Nov. 20, 2025$9.01
Nov. 19, 2025$8.99
Nov. 18, 2025$8.74
Nov. 17, 2025$8.77
Nov. 14, 2025$8.99
Nov. 13, 2025$8.98
Nov. 12, 2025$9.04
Nov. 11, 2025$9.13
Nov. 10, 2025$8.71
Nov. 7, 2025$8.31
Nov. 6, 2025$8.50
Nov. 5, 2025$8.58
Nov. 4, 2025$8.97
Nov. 3, 2025$9.31
Oct. 31, 2025$9.73
Oct. 30, 2025$10.25
Oct. 29, 2025$10.21
Oct. 28, 2025$10.45
Oct. 27, 2025$9.33

Key figures

52-week range
$1.70–$15.98Low April 13, 2026; high Sept. 2, 2026
Average daily volume
3.9MPast 3 months
Market value
$1.17B
Dividend yield
—
From 52-week high
−21.96%

Price change

1 month
+0.89%
3 months
+28.56%
Year to date
+28.29%
1 year
+41.70%

$1,000 a year ago

$1,000 put into REPL at the close on Oct. 24, 2025 would be worth $1,417.

Price only, dividends not included.

What Wall Street says about REPL

In the past 90 days, Wall Street firms published 6 rating or price-target actions on REPL: 3 upgrades and 3 raised price targets.

Rating and price-target actions on REPL, past 90 days
ActionRating
JP MorganRaises targetOverweight$20 to $21
JP MorganRaises targetOverweight$17 to $20
WedbushUpgradeNeutral to Outperform$12 to $19
Leerink PartnersUpgradeMarket perform to Outperform$11 to $17
Cantor FitzgeraldUpgradeNeutral to Overweight—
WedbushRaises targetNeutral$9 to $12

Ratings and price targets are the firms’ own opinions, reported as published.

Not investment advice.

About Replimune Group, Inc.

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic immunotherapy product candidates are designed and intended to maximally activate the immune system against cancer. Oncolytic immunotherapy is an emerging drug class. The proprietary RPx platform is based on a novel, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added that are intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. It operates in single segment of developing oncolytic immunotherapies for the treatment of cancer.

Headquarters
Woburn, Mass.
Employees
465
Listed
July 20, 2018
Sector
Health care
Industry
Biological products, (no diagnostic substances)

replimune.com, the company’s website

In WallStreetDigest editions

No WallStreetDigest article about REPL is on the site yet.

  • AMGNAmgen Inc
  • GILDGilead Sciences Inc
  • MRNAModerna, Inc. Common Stock
  • RVMDRevolution Medicines, Inc. Common Stock
  • BIIBBiogen Inc. Common Stock
  • EXELExelixis Inc